2018
DOI: 10.1016/j.jtho.2018.08.1230
|View full text |Cite
|
Sign up to set email alerts
|

P2.04-06 Increased Plasma Cell % and Decreased B-Cells in Tumor Immune Infiltrates Are Associated with Worse Prognosis in Lung Adenocarcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 0 publications
1
10
0
Order By: Relevance
“…MUM1 (also known as IRF4), a member of the IRF family, is expressed mainly in the nucleus of B cells, particularly during the final phase of differentiation into plasma cells [43]. Recent investigations have demonstrated that elevated numbers of plasma cells could be associated with worse prognosis [44]. In a study on prostatic cancer, it was postulated that immunosuppressive IgA+ plasma cells within tumors induced CD8+ cell exhaustion and suppressed anti-tumor cytotoxic T cell responses through PD-L1 and IL-10 [45].…”
Section: Discussionmentioning
confidence: 99%
“…MUM1 (also known as IRF4), a member of the IRF family, is expressed mainly in the nucleus of B cells, particularly during the final phase of differentiation into plasma cells [43]. Recent investigations have demonstrated that elevated numbers of plasma cells could be associated with worse prognosis [44]. In a study on prostatic cancer, it was postulated that immunosuppressive IgA+ plasma cells within tumors induced CD8+ cell exhaustion and suppressed anti-tumor cytotoxic T cell responses through PD-L1 and IL-10 [45].…”
Section: Discussionmentioning
confidence: 99%
“…Extracellular or secreted HSPD1 can modulate the activation and function of various kinds of immune cells [ 15 ]. TIICs serve as key modulators in TME, and their composition is related to the prognosis and therapeutic response of LUAD patients [ 6 , 7 , 8 , 9 , 10 , 11 ]. Therefore, HSPD1 is an interesting molecule for further investigations of its potential as a biomarker for predicting prognosis and immune response and as a therapeutic target for LUAD.…”
Section: Discussionmentioning
confidence: 99%
“…HSPD1 is well known for its modulatory activity on many types of immune cells [ 15 ]. Composition of TIICs is related with clinical outcomes and therapeutic response in LUAD patients [ 6 , 7 , 8 , 9 , 10 , 11 ]. Therefore, it was of interest to investigate an association between HSPD1 expression and TIICs in LUAD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Tumor-in ltrating plasma cells are shown to play a positive role in antitumor immunity, suggesting that the potential of enhanced these response in the design of cancer immunotherapy (50). Lee et al demonstrated that increased Tumor-in ltrating plasma cells are associated with worse survival in lung adenocarcinomas (51). CD8 + T cells can enhance ferroptosis-speci c lipid peroxidation and, in turn, affect the anti-tumor e cacy of immunotherapy (52).…”
Section: Discussionmentioning
confidence: 99%